Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
In the inaugural CEO Insights video, Nick Jue, CEO of ING DiBa, shares insights in an exclusive interview.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Steven van Rijswijk, CEO of ING
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Quebec Precious Metals Eyes Next Eleonore Mine at One-to-One Conference in New York
00:10:00
From Bartender to Billionaire: Jim McCann’s Journey from Social Services to 1-800-Flowers.com | Jim McCann, Founder , 1-800-Flowers.com Inc.
00:10:00
Driving Clean Energy Transition: A Discussion on Renewable Energy Expansion| Eric Francia, CEO, Acen Corp.
00:10:00
Analyzing the Attorney General's DACA Announcement: Legal Realities and Corporate Response | Roger McNamee, CO-Founder, Elevation Partners.
00:10:00
Wol Kolade Discusses Pandemic Impact on Deal-Making | Wol Kolade, Managing Partner, Livingbridge.
00:10:00
Investing in the Future: The Role of Infrastructure in a Changing World
00:00:00
ProMIS Neurosciences reckons it has the only assets to tackle - Eugene William , Promis Neurosciences Inc
00:10:00
Exploring the Impact of Digital Transformation on Commercial Real Estate Financing | Patrick Turner, Managing Director, Veronis Suhler Stevenson Capital Partner.
00:10:00
This week on Captains of Industry, we interview the leader of Africa's largest pharmaceutical manufacturer.
00:00:00
Churchman Lab enables direct mechanistic insights into fundamental biological processes / Stirling Churchman, Ph.D. Professor of Genetics, HMS
00:00:00
Noxopharm details science-driven strategy in new investor presentation - Dr Gisela Mautner Chief Executive Officer and Managing Director, Noxopharm Ltd
00:10:00
Exploring Private Equity and Alternative Investments with Thys van Zyl | Thys van Zyl, CEO, Everest Wealth Management, LLC.